During the past decade, Lankenau Institute for Medical Research conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 12 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lankenau Institute for Medical Research" #1 sponsor was "Abbott Medical Devices" with 3 trials, followed by "Boston Scientific Corporation" with 3 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 3 trials sponsored, "Medtronic" with 2 trials sponsored and "ARYx Therapeutics" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lankenau Institute for Medical Research" #1 collaborator was "Edwards Lifesciences" with 1 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator, "Sharpe-Strumia Research Foundation" with 1 trials as a collaborator and "Takeda Pharmaceuticals North America, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Lankenau Institute for Medical Research" are "Atrial Fibrillation" (4 trials), "Peripheral Arterial Disease" (4 trials), "Bradycardia" (2 trials), "Heart Failure" (2 trials) and "Myocardial Infarction" (2 trials). Many other conditions were trialed in "Lankenau Institute for Medical Research" in a lesser frequency.

Most popular intervention types in "Lankenau Institute for Medical Research" are "Device" (19 trials), "Drug" (9 trials), "Combination Product" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Micra Pacemaker Implant" (2 trials), "ATI-5923" (1 trials), "ATS 3f® Aortic Bioprosthesis, Model 1000, 19mm" (1 trials), "Amulet Left Atrial Appendage Occluder" (1 trials) and "Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lankenau Institute for Medical Research" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Lankenau Institute for Medical Research". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Lankenau Institute for Medical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Lankenau Institute for Medical Research, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 16 trials that are defined as “Not Applicable".